Symptomtext
ACTHIB being reconstituted with sterile water with no adverse event; Initial information received on 07-Dec-2021 regarding an unsolicited valid non-serious case from nurse via regulatory agency (under reference number 00888121). This case involves a 7 months old male patient who received HIB (PRP/T) VACCINE [ACT-HIB] that was being reconstituted with sterile water (product preparation issue) . The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, HEPATITIS B VACCINE RHBSAG (YEAST), PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, POLIO VACCINE INACT 3V (VERO), TETANUS VACCINE TOXOID (PEDIARIX); PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13); and ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ) via unknown route in unknown administration site for prophylactic vaccination on an unknown date. On 03-Dec-2021, the patient received a third 0.5 ml dose of suspect HIB (PRP/T) VACCINE (lot UJ587AA and expiry date: 17-Sep-2022) via intramuscular route in the left thigh for prophylactic vaccination. It was a case of actual medication error due to inappropriate reconstitution technique (same day latency). It was reported " (Registered Nurse) RN calling in regards to ACTHIB being reconstituted with sterile water. Caller would like advise to know how to proceed after product was administered to a patient." At time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.